Advertisement
Screener

Arcus Biosciences, Inc. (RCUS) Market Cap

Arcus Biosciences, Inc. (RCUS) Market Cap

  • 2026-09-03: Market Cap $3.84B.
  • 2026-07-30: Market Cap $3.6B.
  • 2026-06-30: Market Cap $3.92B.
  • 2026-04-30: Market Cap $3.21B.

Historical market capitalization from contemporaneous retained split-adjusted close and filed split-adjusted shares outstanding.

Available history
2018-03-31 to 2026-09-03
Data captured

Historical Market Cap

DateMarket Cap
2026-09-03$3.84B
2026-07-30$3.6B
2026-06-30$3.92B
2026-04-30$3.21B
2026-03-31$2.71B
2026-02-19$2.44B
2025-12-31$2.99B
2025-10-23$1.81B
2025-09-30$1.46B
2025-08-01$974.91M
2025-06-30$866.1M
2025-05-01$912.73M
2025-03-31$831.32M
2025-02-19$1.17B
2024-12-31$1.37B
2024-10-30$1.46B
2024-09-30$1.4B
2024-08-01$1.44B
2024-06-30$1.39B
2024-05-01$1.41B
2024-03-31$1.72B
2024-02-14$1.45B
2023-12-31$1.44B
2023-11-01$1.18B
2023-09-30$1.34B
2023-08-02$1.43B
2023-06-30$1.51B
2023-05-03$1.36B
2023-03-31$1.33B
2023-02-17$1.48B
2022-12-31$1.51B
2022-10-28$2.01B
2022-09-30$1.89B
2022-07-29$1.92B
2022-06-30$1.83B
2022-04-29$1.74B
2022-03-31$2.26B
2022-02-12$2.08B
2021-12-31$2.87B
2021-10-29$2.35B
2021-09-30$2.45B
2021-07-30$2.24B
2021-06-30$1.96B
2021-04-30$2.4B
2021-03-31$1.99B
2021-02-12$2.55B
2020-12-31$1.69B
2020-10-31$1.42B
2020-09-30$1.11B
2020-07-31$1.28B
2020-06-30$1.46B
2020-04-30$1.22B
2020-03-31$638.24M
2020-02-28$699.73M
2019-12-31$463.84M
2019-10-30$344.4M
2019-09-30$417.17M
2019-07-30$366.79M
2019-06-30$364.54M
2019-04-29$467.17M
2019-03-31$556.24M
2019-03-01$532.63M
2018-12-31$479.67M
2018-11-01$470.32M
2018-09-30$619.68M
2018-08-01$512.59M
2018-06-30$544.15M
2018-05-01$670.82M
2018-03-31$686.37M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Dyne Therapeutics, Inc. (DYN)United States$3.084B-7.09
Arcutis Biotherapeutics, Inc. (ARQT)United States$3.303B115.47
Enliven Therapeutics, Inc. (ELVN)United States$3.307B-35.07
Amylyx Pharmaceuticals, Inc. (AMLX)United States$3.361B-13.15
IDEAYA Biosciences, Inc. (IDYA)United States$3.540B-20.52
Organon & Co. (OGN)United States$3.603B17.03
PRECIGEN, INC. (PGEN)United States$2.757B-12.94
NewAmsterdam Pharma Co N.V. (NAMS)$2.719B-15.37
Xenon Pharmaceuticals Inc. (XENE)$3.684B-14.27
MBX Biosciences, Inc. (MBX)United States$2.664B-25.36